CBD NEWS
CV Sciences Launches Two Gummies CV Sciences launched PlusCBD Calm and Sleep, two gummies that support healthy stress responses and sleep cycles. The gummies contain no artificial flavoring or sweeteners. Each PlusCBD Calm gummy contains 10 mg of CBD derived from sustainable hemp and two neurologically active amino acids: 5-HTP and L-Theanine. Studies have shown that 5-HTP (5-hydroxytryptophan) is a direct precursor for synthesis of the neurotransmitter serotonin, which may facilitate calm feelings and a positive mood. L-Theanine is an amino acid found in green tea that has been extensively researched for stress management. The company said the synergy between L-Theanine and 5-HTP, together with PlusCBD, promotes a balanced brain chemistry, which may help consumers manage occasional anxiety that can result from life’s stressors. PlusCBD Sleep gummies also contain 10 mg of CBD, in
addition to such active ingredients as melatonin, magnolia bark and lemon balm, which work together to support a healthy circadian rhythm. Preclinical studies have shown that compounds found in magnolia bark extract may soothe nerves through the modulation of certain neurotransmitters, including GABA, and also work with the endocannabinoid system to support relaxation. Lemon balm also contains active compounds that support the GABA neurotransmitter system, which studies have linked to promoting restful sleep. The San Diego-based company noted that its latest offerings are third-party tested and formulated by trusted experts to ensure each product contains meaningful amounts of active ingredients that are scientifically researched. The new gummies are available from the Plus CBD website and will be at retailers later this year.
Medterra and Acreage Announce Joint Venture Acreage Holdings, a vertically integrated, multistate operator of cannabis licenses and assets in the United States, announced that its subsidiary, Universal Hemp, reached an agreement with Medterra CBD. The partnership allows Acreage Holdings to tap into Medterra’s innovation pipeline, high-quality CBD and significant e-commerce platform for immediate nationwide distribution. Medterra subsidiary Five Farms CBD will develop a full-spectrum CBD collection under The Botanist, an Acreage Holdings brand. The companies said the partnership marks the first time in the cannabis industry that a CBD and a publicly traded cannabis brand have collaborated. J.P. Larsen, co-founder of Medterra and president of Five Farms, said this is “the future of CBD and cannabis companies.” Acreage will license The Botanist brand to Five Farms, which will manufacture, market and sell The Botanist branded CBD products through Medterra’s e-commerce platform. The Botanist branded CBD is expected to be available in the second half of 2021. 34
July 2021 DRUGSTORENEWS.COM
034-036_DSN_CBDNews_0721_v4.indd 34
7/9/21 11:43 PM